Explain this page
Arphra AIPlain-English read on Jabil Inc.’s valuationRatios & metrics
Profitability, returns on capital, growth, and credit — all derived from the historical income statement, balance sheet, and cash flow rows in our data warehouse.
Valuation multiples
Price- and EV-based multiples plus shareholder yields. Snapshot at each fiscal year-end from key_metrics (FMP).
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Headline | ||||||||
| Market cap | — | — | — | — | — | — | — | — |
| Enterprise value | — | — | — | — | — | — | — | — |
| Multiples | ||||||||
| P / E | — | — | — | — | — | — | — | — |
| P / B | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / Sales | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
| Yields | ||||||||
| Earnings yield | — | — | — | — | — | — | — | — |
| Free cash flow yield | — | — | — | — | — | — | — | — |
| Dividend yield | — | — | — | — | — | — | — | — |
Profitability
Margin structure across the last 5 fiscal years
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin | +8.06% | +7.86% | +8.26% | +9.26% | +8.88% | +8.81% | +8.58% | +9.01% |
| Operating margin | +3.60% | +4.16% | +4.43% | +6.97% | +3.97% | +5.10% | +5.18% | +5.10% |
| EBITDA margin | +6.64% | +6.88% | +6.89% | +9.07% | +6.07% | +7.35% | +7.15% | +7.20% |
| EBIT margin | +3.65% | +4.11% | +4.23% | +6.66% | +3.81% | +4.78% | +5.04% | +4.82% |
| Pre-tax margin | +3.22% | +3.68% | +3.64% | +6.06% | +2.99% | +4.22% | +4.32% | +4.33% |
| Net margin | +2.38% | +2.98% | +2.36% | +4.81% | +2.20% | +3.06% | +3.19% | +3.21% |
| Cost structure | ||||||||
| Cost of revenue / sales | +91.94% | +92.14% | +91.74% | +90.74% | +91.12% | +93.35% | +93.22% | +91.24% |
| R&D intensity | +0.12% | +0.10% | +0.10% | +0.14% | +0.09% | +0.11% | +0.11% | +0.11% |
| SG&A intensity | +4.14% | +3.45% | +3.48% | +4.02% | +3.76% | +3.78% | +3.68% | +3.79% |
| Effective tax rate | +26.06% | +19.09% | +35.18% | +20.73% | +26.35% | +27.78% | +26.19% | +26.92% |
Returns on capital
ROE / ROA / ROC / ROIC over the relevant capital base, plus the 3-step DuPont decomposition of ROE.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Returns | ||||||||
| Return on equity (ROE) | +32.57% | +40.62% | +28.53% | +79.91% | +43.31% | +45.80% | +48.06% | +50.73% |
| Return on assets (ROA) | +4.18% | +5.05% | +4.21% | +8.00% | +3.54% | +5.15% | +5.23% | +5.27% |
| Return on capital (ROC) | +19.34% | +23.76% | +25.13% | +40.31% | +24.21% | +29.45% | +29.71% | +29.66% |
| Return on invested capital (ROIC) | +12.76% | +16.99% | +13.38% | +27.79% | +13.45% | +17.65% | +18.30% | +18.69% |
| Asset turnover | +175.84% | +169.79% | +178.66% | +166.46% | +160.72% | +168.49% | +163.76% | +163.98% |
| DuPont · ROE decomposition | ||||||||
| Net margin | +2.38% | +2.98% | +2.36% | +4.81% | +2.20% | +3.06% | +3.19% | +3.21% |
| Asset turnover (× revenue / assets) | +175.84% | +169.79% | +178.66% | +166.46% | +160.72% | +168.49% | +163.76% | +163.98% |
| Equity multiplier (× assets / equity) | +779.32% | +804.12% | +677.50% | +998.91% | +1222.35% | +888.60% | +919.29% | +962.66% |
Activity & efficiency
Turnover ratios and days-outstanding — how efficiently the business converts assets and working capital into sales and cash.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||
| Asset turnover | 1.76 | 1.70 | 1.79 | 1.66 | 1.61 | 1.68 | 1.64 | 1.64 |
| Fixed-asset turnover | 6.56 | 7.52 | 9.90 | 8.54 | 9.01 | — | — | — |
| Inventory turnover | 6.10 | 5.03 | 6.12 | 6.13 | 5.80 | — | — | — |
| Receivables turnover | 7.08 | 6.45 | 7.41 | 6.27 | 5.85 | — | — | — |
| Payables turnover | 3.94 | 3.85 | 5.61 | 4.23 | 3.42 | — | — | — |
| Days outstanding | ||||||||
| Days sales outstanding (DSO) | 51.59 | 56.60 | 49.25 | 58.18 | 62.41 | — | — | — |
| Days inventory outstanding (DIO) | 59.83 | 72.51 | 59.69 | 59.55 | 62.92 | — | — | — |
| Days payables outstanding (DPO) | 92.73 | 94.73 | 65.11 | 86.21 | 106.68 | — | — | — |
| Cash conversion cycle | 18.69 | 34.37 | 43.82 | 31.52 | 18.65 | — | — | — |
Cash flow quality
How well reported earnings translate into operating and free cash flow, plus reinvestment intensity.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Operating CF / Net income | 2.06 | 1.66 | 2.12 | 1.24 | 2.50 | 1.84 | 1.67 | 1.75 |
| FCF / Net income | 0.39 | 0.27 | 0.86 | 0.67 | 1.78 | 1.01 | 0.95 | 0.96 |
| FCF margin | +0.94% | +0.79% | +2.03% | +3.23% | +3.93% | +3.09% | +3.02% | +3.10% |
| OCF margin | +4.89% | +4.93% | +5.00% | +5.94% | +5.50% | +5.64% | +5.32% | +5.63% |
| CapEx / Revenue | +3.96% | +4.14% | +2.97% | +2.71% | +1.57% | +2.47% | +2.36% | +2.39% |
| CapEx / D&A | 1.32 | 1.50 | 1.11 | 1.13 | 0.69 | — | — | — |
| Stock-based comp / Revenue | +0.35% | +0.24% | +0.27% | +0.31% | +0.36% | — | — | — |
Per-share & shareholder yield
EPS, book value, sales, cash flow and dividends per share — plus payout / retention.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| EPS · diluted | 4.58 | 6.90 | 6.02 | 11.17 | 5.92 | 12.32 | 14.47 | 16.99 |
| EPS · basic | 4.69 | 7.05 | 6.15 | 11.34 | 6.00 | 12.42 | 14.55 | 17.25 |
| Book value / share | 14.05 | 16.98 | 21.10 | 13.97 | 13.68 | 20.50 | 22.48 | 23.03 |
| Tangible BV / share | 8.15 | 11.01 | 15.48 | 7.51 | 3.63 | 20.50 | 22.48 | 23.03 |
| Sales / share | 192.54 | 231.84 | 255.35 | 232.37 | 268.73 | 306.98 | 338.44 | 363.47 |
| Operating CF / share | 9.42 | 11.43 | 12.76 | 13.81 | 14.79 | 17.32 | 18.00 | 20.48 |
| Free cash flow / share | 1.80 | 1.84 | 5.18 | 7.50 | 10.57 | 9.48 | 10.21 | 11.27 |
| Dividends / share | 0.33 | 0.33 | 0.33 | 0.34 | 0.32 | 0.40 | 0.44 | 0.49 |
| Payout ratio | +7.18% | +4.82% | +5.50% | +3.03% | +5.48% | +4.30% | +4.03% | +4.15% |
| Retention ratio | +92.82% | +95.18% | +94.50% | +96.97% | +94.52% | +95.70% | +95.97% | +95.85% |
Growth
Year-over-year change for headline P&L lines, plus through-cycle CAGR
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 7y CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Top-line | |||||||||
| Revenue · YoY | — | +14.32% | +3.66% | -16.77% | +3.18% | +14.36% | +9.22% | +7.40% | +4.55% |
| Gross profit · YoY | — | +11.57% | +8.93% | -6.66% | -1.12% | +13.43% | +6.44% | +12.76% | +6.23% |
| Profit | |||||||||
| Operating income · YoY | — | +32.04% | +10.34% | +30.97% | -41.28% | +47.16% | +10.93% | +5.62% | +9.86% |
| EBITDA · YoY | — | +18.42% | +3.91% | +9.53% | -30.92% | +38.49% | +6.14% | +8.21% | +5.77% |
| Net income · YoY | — | +43.10% | -17.87% | +69.68% | -52.67% | +58.68% | +13.99% | +8.12% | +9.15% |
| Operating | |||||||||
| EBIT · YoY | — | +28.93% | +6.61% | +31.06% | -40.96% | +43.54% | +15.02% | +2.76% | +8.80% |
| R&D · YoY | — | -2.94% | +3.03% | +14.71% | -33.33% | +40.57% | +9.58% | +8.78% | +3.60% |
| Per-share | |||||||||
| EPS · diluted · YoY | — | +50.66% | -12.75% | +85.55% | -47.00% | +108.05% | +17.48% | +17.42% | +20.60% |
| EPS · basic · YoY | — | +50.32% | -12.77% | +84.39% | -47.09% | +107.05% | +17.11% | +18.57% | +20.45% |
Credit & leverage
Balance-sheet health + interest coverage + liquidity. Coverage ratios use period-end debt and trailing interest expense.
ActualEstimate
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E |
|---|---|---|---|---|---|---|---|---|
| Leverage | ||||||||
| Total debt | $3.32B | $3.41B | $3.25B | $3.26B | $3.37B | $3.63B | $4.02B | $4.34B |
| Net debt | $1.75B | $1.93B | $1.44B | $1.06B | $1.43B | $1.47B | $1.66B | $1.7B |
| Net debt / EBITDA | 0.90 | 0.84 | 0.60 | 0.40 | 0.79 | 0.59 | 0.62 | 0.59 |
| Debt / equity | 1.55 | 1.39 | 1.13 | 1.88 | 2.22 | 1.60 | 1.63 | 1.71 |
| Debt / assets | +19.93% | +17.30% | +16.72% | +18.77% | +18.15% | +17.95% | +17.69% | +17.80% |
| Equity / assets | +12.83% | +12.44% | +14.76% | +10.01% | +8.18% | +11.25% | +10.88% | +10.39% |
| Coverage | ||||||||
| EBITDA / interest expense | 14.95 | 15.25 | 11.61 | 15.14 | 7.42 | 10.79 | 10.43 | 10.45 |
| Operating income / interest | 8.12 | 9.23 | 7.46 | 11.64 | 4.84 | 7.49 | 7.57 | 7.40 |
| Interest expense | $130M | $151M | $206M | $173M | $244M | $232.27M | $255.02M | $275.39M |
| Liquidity | ||||||||
| Current ratio | 1.02 | 1.02 | 1.16 | 1.09 | 1.00 | — | — | — |
| Quick ratio | 0.53 | 0.49 | 0.51 | 0.58 | 0.51 | — | — | — |
| Cash ratio | 0.15 | 0.11 | 0.14 | 0.19 | 0.14 | — | — | — |
| Working capital | $194M | $211M | $2.04B | $1.01B | $6M | — | — | — |
| Working capital / revenue | +0.66% | +0.63% | +5.86% | +3.49% | +0.02% | — | — | — |
Methodology. ROE / ROA / ROC use period-end balance-sheet denominators (no average-of- period smoothing). ROIC = Operating Income × (1 − inferred effective tax rate) over invested capital, with the effective tax inferred from net-to-operating income when both are positive and a 25% default otherwise. Net debt / EBITDA, debt ratios, and interest-coverage ratios are calculated point-in-time at each fiscal year-end. TTM = trailing 4 quarters (income / cash flow summed, balance sheet = most-recent quarterly snapshot). Through-cycle CAGR in the Growth panel uses the geometric mean of first-to-last period growth across the window (positive values only).